Francine Behar-Cohen
Fondatore presso Eyevensys SAS
Profilo
Francine Behar-Cohen is the founder.
She founded Kiora Pharmaceuticals, Inc. in 1998, EarlySight SA in 2019, and Eyevensys SAS in 2008.
At Eyevensys SAS, she holds the title of Director & Chief Innovation Officer.
Posizioni attive di Francine Behar-Cohen
Società | Posizione | Inizio |
---|---|---|
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Fondatore | 08/12/2008 |
Precedenti posizioni note di Francine Behar-Cohen
Società | Posizione | Fine |
---|---|---|
EarlySight SA
EarlySight SA Medical SpecialtiesHealth Technology EarlySight SA engages in the development, production, and marketing of imaging solutions for the medical and life science sectors. It focuses primarily on the development of an eye camera for the monitoring of the tissue degenerative process associated with retinal diseases. The company was founded by Timothé Laforest, Mathieu Kunzi, Christophe Moser, and Francine Behar-Cohen in 2019 and is headquartered in Lausanne, Switzerland. | Fondatore | - |
KIORA PHARMACEUTICALS, INC. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
KIORA PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Commercial Services |
EarlySight SA
EarlySight SA Medical SpecialtiesHealth Technology EarlySight SA engages in the development, production, and marketing of imaging solutions for the medical and life science sectors. It focuses primarily on the development of an eye camera for the monitoring of the tissue degenerative process associated with retinal diseases. The company was founded by Timothé Laforest, Mathieu Kunzi, Christophe Moser, and Francine Behar-Cohen in 2019 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Francine Behar-Cohen